SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001845459-23-000015
Filing Date
2023-11-14
Accepted
2023-11-14 16:39:00
Documents
79
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q nkgn-20230930.htm   iXBRL 10-Q 1953706
2 EX-31.1 nkgen-q3202310qexhibit311.htm EX-31.1 8245
3 EX-31.2 nkgen-q3202310qexhibit312.htm EX-31.2 8274
4 EX-32.1 nkgen-q3202310qexhibit321.htm EX-32.1 5794
  Complete submission text file 0001845459-23-000015.txt   8196678

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nkgn-20230930.xsd EX-101.SCH 63948
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT nkgn-20230930_cal.xml EX-101.CAL 68531
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT nkgn-20230930_def.xml EX-101.DEF 396443
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nkgn-20230930_lab.xml EX-101.LAB 704451
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nkgn-20230930_pre.xml EX-101.PRE 526306
73 EXTRACTED XBRL INSTANCE DOCUMENT nkgn-20230930_htm.xml XML 859341
Mailing Address 3001 DAIMLER ST, SANTA ANA CA 92705
Business Address 3001 DAIMLER ST, SANTA ANA CA 92705 (949) 396-6830
NKGen Biotech, Inc. (Filer) CIK: 0001845459 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40427 | Film No.: 231407252
SIC: 2836 Biological Products, (No Diagnostic Substances)